- This event has passed.
18.15 – Registration in the Darwin Lecture Theatre (Darwin Building, UCL)
18.45 – Welcome – Dr. Emily Culme-Seymour, LRMN
18.50 – ‘Advancing Cell Therapies for Multiple Therapeutic Targets: Accelerating Market Success’ – Dr. Robin L. Smith, CEO, NeoStem, Inc. (New York, NY, US)
19.20 – Q & A
19.25 – ‘Human Embryonic Stem Cells: Opportunities and Practical Challenges’ – Dr. Michael D. West, CEO, BioTime, Inc. (Alameda, CA, US)
19.55 – Q & A
20.00 – ‘Building a Regenerative Medicine Company – Commercial Stage Considerations’ – Mr Geoff MacKay, CEO, Organogenesis Inc. (Canton, MA, US)
20.30 – Q & A
20.35 – Closing remarks – Prof. Chris Mason, Advanced Centre for Biochemical Engineering, UCL
20.40 – 22.00 – LRMN Reception – Network whilst enjoying a glass of wine or two in the Roberts Foyer (Roberts Building, UCL)
SPONSORS + PARTNERS
CORPORATE SPONSOR: PeproTech
PROMOTIONAL SUPPORT: ‘Regenerative Medicine’
PLEASE NOTE THAT DUE TO LECTURE THEATRE SEATING CAPACITY, IF YOU WISH TO ATTEND THIS EVENT YOU MUST REGISTER, OTHERWISE UNFORTUNATELY YOU WILL NOT BE ABLE TO GAIN ADMISSION. Seat allocation is on a first come, first served basis. If you wish to attend, all that is required is to email email@example.com with ‘I will attend’ in the subject box. Please only register if you can definitely make the meeting. If you have to cancel later do please let us know.
The LRMN Team very much look forward to welcoming you at 6.15 pm on Tuesday 26th November 2013 for an event that will focus on the very latest in cell therapy commercialisation.